AstraZeneca announces changes to Senior Executive Team
AstraZeneca unveiled changes to its executive leadership team...
15 January 2013 | By AstraZeneca
AstraZeneca unveiled changes to its executive leadership team...
List view / Grid view
AstraZeneca unveiled changes to its executive leadership team...
15 January 2013 | By AstraZeneca
AstraZeneca unveiled changes to its executive leadership team...
NEXIUM 20mg retail launch targeted for 2014, subject to regulatory…
13 August 2012 | By AstraZeneca
NEXIUM 20mg retail launch targeted for 2014, subject to regulatory approval...
AstraZeneca will present key results from health economics sub-studies...
21 October 2011 | By AstraZeneca
AstraZeneca will present key results from health economics sub-studies...
AstraZeneca announced that FASLODEX™ (fulvestrant) has received regulatory approval...
26 September 2011 | By AstraZeneca
AstraZeneca announced that FASLODEX™ (fulvestrant) has received regulatory approval...
AstraZeneca announced that AXANUM has received positive agreement for approval...
2 August 2011 | By AstraZeneca
AstraZeneca announced that AXANUM has received positive agreement for approval...
NEXIUM 10 mg and 20 mg capsules have received regulatory…
1 July 2011 | By AstraZeneca
NEXIUM 10 mg and 20 mg capsules have received regulatory approval in Japan...
AstraZeneca signs agreement with Daiichi Sankyo for denosumab for the…
24 May 2011 | By AstraZeneca
AstraZeneca signs agreement with Daiichi Sankyo for denosumab for the treatment of bone disorders...
New health economics data from a substudy of the PLATO…
9 May 2011 | By AstraZeneca
New health economics data from a substudy of the PLATO trial...